0001209191-17-041623.txt : 20170623
0001209191-17-041623.hdr.sgml : 20170623
20170623145757
ACCESSION NUMBER: 0001209191-17-041623
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170619
FILED AS OF DATE: 20170623
DATE AS OF CHANGE: 20170623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: XBiotech Inc.
CENTRAL INDEX KEY: 0001626878
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8201 E. RIVERSIDE DRIVE
STREET 2: BUILDING 4, SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
BUSINESS PHONE: 512-386-2930
MAIL ADDRESS:
STREET 1: 8201 E. RIVERSIDE DRIVE
STREET 2: BUILDING 4, SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STECHER MICHAEL
CENTRAL INDEX KEY: 0001639077
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37347
FILM NUMBER: 17927329
MAIL ADDRESS:
STREET 1: 8201 E RIVERSIDE DRIVE
STREET 2: BLDG 4, STE 100
CITY: AUSTIN
STATE: TX
ZIP: 78744
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2017-06-19
2017-06-23
0
0001626878
XBiotech Inc.
XBIT
0001639077
STECHER MICHAEL
8801 GALLANT FOX ROAD
AUSTIN
TX
78737
0
1
0
0
Medical Director
Stock Option
4.24
2017-06-19
4
M
0
50000
4.24
A
2018-06-19
2027-06-19
Common Stock
50000
50000
D
On June 19, 2017 (the Grant Date) the reporting person was granted incentive stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in three equal annual installments commencing as of the first anniversary of the Grant Date with an expiry of ten years from the Grant Date.
/s/ Ashley Otero under Power of Attorney for Micheal Stecher
2017-06-23
EX-24.4A_732979
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints David G. Andersen, Queena Han, or Ashley Otero with full power of
substitution, as the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of XBiotech Inc. or any successor thereto
(the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules thereunder (the "Exchange Act"),
Form 144 in accordance with Rule 144 under the Securities Act of 1933 ("Rule
144") and any other forms or reports, including, but not limited to, a Form ID,
that the undersigned may be required to file in connection with the
undersigned's ownership, acquisition or disposition of securities of the
Company;
(2) do and perform any and all acts for and on behalf of the undersigned, which
may be necessary or desirable to complete and execute any such Form 3, 4 or 5,
Form 144 or other form or report, complete and execute any amendment or
amendments thereto and timely file such form or report with the Securities and
Exchange Commission and any stock exchange or similar authority; and
(3) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act or Rule 144.
This Power of Attorney revokes any previous Power of Attorney filed with
the Company for the purposes set forth herein and shall remain in full force and
effect until the undersigned is no longer required to file Forms 3, 4 and 5 with
respect to the undersigned's holdings of and transactions in securities issued
by the Company, unless expressly revoked before that time.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 23rd day of June 2017.
/s/ Michael Stecher
-------------------------------------
Michael Stecher